Literature DB >> 29263722

Enhanced bone healing and decreased pain in sacral insufficiency fractures after teriparatide treatment: retrospective clinical-based observational study.

Yuji Kasukawa1,2, Naohisa Miyakoshi1,2, Toshihito Ebina3, Michio Hongo1,2, Yoshinori Ishikawa1,2, Daisuke Kudo1,2, Koji Nozaka1,2, Yoichi Shimada1,2.   

Abstract

The purpose of this retrospective clinical-based observational study was to evaluate the effects of teriparatide (TPTD) on clinical outcomes and radiologic findings of sacral insufficiency fractures (SIFs). Seven elderly women with SIFs received TPTD for at least 6 months. We evaluated the symptoms, pain, and radiological findings. At their initial clinic visit, 86% patients could not walk or sit. Computed tomography (CT) images revealed sacral wing fracture in 6 patients, and bone scintigram showed H-shaped uptake over the bilateral sacral wings in 1 patient. After the treatment, 5 patients could walk. Mean visual analog scale score was significantly lower after (12.9 mm) than before (87.4 mm) TPTD treatment (p < 0.0001). CT images revealed bone union (four patients) and sclerotic changes (three patients) at the fracture sites. Seven elderly women with SIFs had significant improvement in pain and demonstrated bone union or sclerotic changes at fracture sites by TPTD.

Entities:  

Keywords:  bone union; fracture healing; low back pain; mobility; sacral insufficiency fracture; teriparatide

Year:  2017        PMID: 29263722      PMCID: PMC5726198          DOI: 10.11138/ccmbm/2017.14.1.140

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  25 in total

1.  [Not Available].

Authors:  J G Harms; D Jeszenszky
Journal:  Oper Orthop Traumatol       Date:  1998-06       Impact factor: 1.154

2.  Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women.

Authors:  Peter Peichl; Lukas A Holzer; Richard Maier; Gerold Holzer
Journal:  J Bone Joint Surg Am       Date:  2011-09-07       Impact factor: 5.284

3.  Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34).

Authors:  Yaser M Alkhiary; Louis C Gerstenfeld; Elizabeth Krall; Michael Westmore; Masahiko Sato; Bruce H Mitlak; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2005-04       Impact factor: 5.284

4.  Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures.

Authors:  Per Aspenberg; Harry K Genant; Torsten Johansson; Antonio J Nino; Kyoungah See; Kelly Krohn; Pedro A García-Hernández; Christopher P Recknor; Thomas A Einhorn; Gail P Dalsky; Bruce H Mitlak; Anke Fierlinger; Mark C Lakshmanan
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

Review 5.  Sacral stress fractures.

Authors:  Julie T Lin; Joseph M Lane
Journal:  J Womens Health (Larchmt)       Date:  2003-11       Impact factor: 2.681

6.  Cement augmentation of the navigated iliosacral screw in the treatment of insufficiency fractures of the sacrum: a new method using modified implants.

Authors:  Dirk Wähnert; Michale J Raschke; Thomas Fuchs
Journal:  Int Orthop       Date:  2013-04-04       Impact factor: 3.075

Review 7.  Percutaneous treatment of insufficiency fractures : principles, technique and review of literature.

Authors:  Douglas P Beall; Abhijit Datir; Sharon L D'Souza; Logan S D'Souza; Divya Gunda; John Morelli; Michael Brandon Johnson; Nima Nabavizadeh
Journal:  Skeletal Radiol       Date:  2010-02       Impact factor: 2.199

8.  Efficacy and safety of percutaneous sacroplasty for painful osteoporotic sacral insufficiency fractures: a prospective, multicenter trial.

Authors:  Michael E Frey; Michael J DePalma; David X Cifu; Sarjoo M Bhagia; Jonathan S Daitch
Journal:  Spine (Phila Pa 1976)       Date:  2007-07-01       Impact factor: 3.468

Review 9.  Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.

Authors:  René Rizzoli; Jean-Yves Reginster; Steven Boonen; Gérard Bréart; Adolfo Diez-Perez; Dieter Felsenberg; Jean-Marc Kaufman; John A Kanis; Cyrus Cooper
Journal:  Calcif Tissue Int       Date:  2011-06-03       Impact factor: 4.333

10.  Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS).

Authors:  A Fahrleitner-Pammer; B L Langdahl; F Marin; F Jakob; D Karras; A Barrett; Ö Ljunggren; J B Walsh; G Rajzbaum; C Barker; W F Lems
Journal:  Osteoporos Int       Date:  2010-11-27       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.